Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Pregnancy Outcome in Type 1 Diabetes
NCT03765359Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 1 diabetes mellitus (T1D), sponsored by Tampere University Hospital. Started Aug 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03765359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765359.